Semaglutide
Semaglutide is a potent synthetic analog of the endogenous human incretin hormone, Glucagon-Like Peptide-1 (GLP-1). In the field of advanced metabolic and endocrinology research, Semaglutide is a cornerstone compound for investigating glycemic control, weight management, and cardiovascular risk reduction. Engineered for enhanced stability, its structure includes a specific fatty acid side chain that allows for high albumin binding and significant resistance to enzymatic degradation by dipeptidyl peptidase-4 (DPP-4). This modification provides researchers with a long-acting experimental model to study sustained GLP-1 receptor activation and its multifaceted effects on insulin secretion, glucagon suppression, and delayed gastric emptying.
Our Semaglutide is synthesized in an ISO 9001:2015 certified and GMP-grade manufacturing environment. By utilizing state-of-the-art solid-phase synthesis and rigorous multi-stage HPLC purification, we achieve an ultra-high chemical purity of ≥99%. This meticulous production standard ensures the peptide is free from truncated sequences and residual chemical catalysts, providing the high-fidelity results necessary for accurate studies into receptor binding affinity and long-term metabolic signaling.
Research Applications & Mechanisms
Incretin System Modulation
Investigating the potentiation of glucose-dependent insulin secretion and the regulation of pancreatic beta-cell function in experimental diabetic models.
Central Appetite Regulation
Researching the peptide’s interaction with GLP-1 receptors in the hypothalamus and hindbrain to study its influence on satiety signaling and food intake behavior.
Adipose Tissue & Lipid Metabolism
Studying the mechanisms through which sustained GLP-1 activation influences lipogenesis, fat oxidation, and visceral adipose tissue reduction.
Cardiovascular & Renal Signaling
Exploring the potential anti-inflammatory and protective effects of Semaglutide in vascular and renal epithelial cell research models.
Technical Specifications
| Parameter | Laboratory Standard |
| Compound | Semaglutide (GLP-1 Analog) |
| Agonist Type | Selective GLP-1 Receptor Agonist |
| Production Quality | GMP-Level Compliance |
| Purity (HPLC) | ≥99% (Pharmaceutical Grade) |
| Physical Appearance | Fine, Smooth & Flat Lyophilized Cake |
| Molecular Formula | C187H291N45O59 |
| Concentration | 5mg / 10mg / 15mg / 20mg / 30mg vials |
| Solubility | Highly Soluble in Water / Bacteriostatic Water |
| Batch Control | MS & HPLC Analysis Verified |
Key Features & Quality Assurance
Pharmaceutical-Grade Lyophilization
Our proprietary vacuum-sealing process ensures the Semaglutide powder surface is perfectly smooth, flat, and delicate. This uniform “cake” structure ensures rapid reconstitution and maintains the structural integrity of the complex fatty acid-linked peptide chain.
Superior Molecular Stability
The specific chemical modifications of our synthetic Semaglutide ensure a high resistance to proteolytic cleavage, allowing for extended observation windows in both in-vitro and in-vivo research designs.
Reconstitution & Storage
Reconstitution Guide
-
Preparation: Allow the vial to reach room temperature. Centrifuge for 30-60 seconds to ensure the Semaglutide cake is at the base.
-
Solvent: Reconstitute with Sterile Water or Bacteriostatic Water.
-
Technique: Gently introduce the diluent against the vial wall. DO NOT SHAKE; swirl gently until the solution is clear and transparent.
Storage Protocols
-
Long-term: Store at -20°C (Maintains potency for up to 24 months).
-
Short-term: Stable at 2–8°C for up to 3 months.
-
Post-Reconstitution: Store at 2–8°C and utilize within 14-21 days for optimal results.
Shipping & Documentation
-
Global Logistics: Shipped in discreet, temperature-controlled packaging to protect the Semaglutide molecular structure.
-
Verified Quality: A batch-specific Certificate of Analysis (COA) and HPLC/MS reports are available for every order.
-
Reshipment Policy: We provide a guaranteed reshipment policy for any lost or customs-intercepted orders (terms apply).
⚠️ Research Disclaimer
Product-Specific Safety Notice: This Semaglutide is strictly for laboratory research and analytical purposes. It is NOT intended for human or veterinary administration. All research must be conducted by qualified professionals.
Scientific Resources & References
-
PubMed – NIH: Clinical studies on Semaglutide for type 2 diabetes and obesity management
-
ScienceDirect (Elsevier): Advanced Research on GLP-1 Analogs and Metabolic Syndrome
🔍 Deep Dive Research
-
[Technical Guide]: How to Reconstitute and Store Lyophilized Peptides for Maximum Potency
-
[Metabolic Study]: Beyond Glucose Control: The Role of Semaglutide in Adipose Tissue Research
siktzy –
Order was correct.